Homeopathy for anxiety and anxiety disorders: A systematic review of the research

Abstract

Objective: To conduct a systematic review of the clinical research evidence on homeopathy in the treatment of anxiety and anxiety disorders.

Methods: A comprehensive search of major biomedical databases: MEDLINE, EMBASE, ClNAHL, PsycINFO, Cochrane Library; and of specialist complementary and alternative medicine (CAM) databases: AMED, CISCOM and Hom-Inform was conducted. Efforts were made to identify unpublished and ongoing research using relevant sources and experts in the field. Relevant research was categorised by study type and appraised according to study design. Clinical commentaries were obtained for studies reporting clinical outcomes.

Results: Eight randomised controlled studies were identified. The types of anxiety and anxiety disorders studied were test anxiety, generalised anxiety disorder and anxiety related to medical or physical conditions such as cancer or surgical procedures. Single case reports/studies were the most frequently encountered study type but other study types including uncontrolled trials/case series and surveys were also found. No relevant qualitative research was identified.

Conclusions: A comprehensive search demonstrates that the evidence on the benefit of homeopathy in anxiety and anxiety disorders is limited. A number of studies of homeopathy in such conditions were located but the randomised controlled trials report contradictory results, are underpowered or provide insufficient details of methodology. Several uncontrolled and observational studies reported positive results including high levels of patient satisfaction but because of the lack of a control group, it is difficult to assess the extent to which any response is due to homeopathy. Adverse effects reported appear limited to ‘remedy reactions’ and included temporary worsening of symptoms and reappearance of old symptoms.

On the basis of this review it is not possible to draw firm conclusions on the efficacy or effectiveness of homeopathy for anxiety. However, surveys suggest that homeopathy is quite frequently used by people suffering from anxiety. If shown to be effective, it is possible that homeopathy may have benefits in terms of adverse effects and acceptability to patients. Consequently, further investigation is indicated. Future research should be of pragmatic design and include qualitative studies.

Keywords

homeopathy - anxiety - anxiety disorders - systematic review

¹ ‘Radionic’ homeopathy is not a recognised form of homeopathy; homeopathic medicines produced by this method are not recognised as such by any homeopathic pharmacopoeia.

• References

• 1 Churchill R, Barbui C, Furukawa T, et al. Depression, anxiety and neurosis group (Collaborative Review Groups). About the Cochrane Collaboration. Cochrane Library 2005, Issue 4.
• 2 Jenkins R. Introduction to Generalised Anxiety. WHO UK Collaborating Centre, 2005. Available at National Library for Health, Mental Health Specialist Library: http://libraries.nelh.nhs.uk/mentalhealth. Accessed March 2006.
• 3 Office for National Statistics. Psychiatric Morbidity among Adults living in Private Households, 2000: Summary Report. London: HMSO, 2000.
• 4 Eisenberg D.M., Davis R.B., Ettner S.L. et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575.
• 5 Unutzer J., Klap R., Sturm R. et al. Mental disorders and the use of the alternative medicine: results from a national survey. Am J Psychiatry 2000; 157 (11) 1851-1857.
• 6 Davidson J., Rampes H., Eisen M. et al. Psychiatric disorders in primary care patients receiving complementary medical treatments. Compr Psychiatry 1998; 39: 16-20.
• 7 Trichard M., Lamure E., Chaufferin G. Study of the practice of homeopathic general practitioners in France. Homeopathy 2003; 92: 135-139.
• 8 Long L., Huntley A., Ernst E. Which complementary and alternative therapies benefit which conditions? A survey of the opinions of 223 professional organizations. Complement Ther Med 2001; 9: 178-185.
• 9 Lockie A. Homeopathy Handbook. London: Dorling Kindersley; 2001.
• 10 Peters D. New Medicine. 2005. London: Dorling Kindersley;
• 11 Thomas K., Nicholl J., Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 2001; 9: 2-11.
• 12 Alternative Healthcare. Market Assessment. London: Key Note; 2001.
• 13 Kleijnen J., Knipschild P., ter Riet G. Clinical trials of homeopathy. BMJ 1991; 302: 316-323.
• 14 Linde K., Clausius N., Ramirez G. et al. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350: 834-843.
• 15 Cucherat M., Haugh M.C., Gooch M., Boissel J.P. Evidence of clinical efficacy of homeopathy: a meta-analysis of clinical trials. Eur J Clin Pharmacol 2000; 56: 27-33.
• 16 Shang A., Huwiler-Müntener K., Nartey L. et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366: 726-732.
• 17 Knaudt P., Connor K., Weisler R., Churchill L., Davidson J. Alternative therapy use by psychiatric outpatients. J Nerv Ment Dis 1999; 187: 692-695.
• 18 Demling J., Neubauer S., Luderer H.J., Worthmuller M. A survey on psychiatric patients’ use of non-medical alternative practitioners: incidence, methods, estimation, and satisfaction. Complement Ther Med 2002; 10 (04) 193-201.
• 19 Van Wassenhoven M., Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy 2004; 93: 3-11.
• 20 CRD (NHS Centre for Reviews and Dissemination) Report Number 4 (2nd edn), Undertaking Systematic Reviews of Research on Effectiveness. York: CRD, 2001.
• 21 Jorm A.F., Christensen H., Griffiths K.M., Parslow R.A., Rodgers B., Blewitt K.A. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust 2004; 181: S29-S46.
• 22 Alibeu J.P., Jobert J. [Aconite in homeopathic relief of post-operative pain and agitation in children.] Aconit en dilution homeopathique et agitation post-operatoire de l’enfant. Pediatrie 1990; 45: 465-466 (Also reported as Alibeu J, Jobert J. Etude sur Aconit en dilution homeopathique sur l’agitation post-operatoire de l’enfant. Homeopathie Francaise 1992; 80:10–12.)
• 23 Baker D.G., Myers S.P., Howden I., Brooks L. The effects of homeopathic Argentum nitricum on test anxiety. Complement Ther Med 2003; 11: 65-71.
• 24 Bonne O., Shemer Y., Gorali Y., Katz M., Shalev A. A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. J Clin Psychiatry 2003; 64: 282-287.
• 25 Hariveau E., Albertini C., Rufo M. Comparaison de Lithium Microsol a lorazepam dans les manifestations anxiodepressives reactionnelles de l’adulte [Comparison of Lithium Microsol with lorazepam in reactive anxiodepressive manifestation in adults.]. Homeopathie Francaise 1991; 79: 59-62.
• 26 Heulluy B. Essai randomisé ouvert de L 72 (spécialité homéopathique) contre diazépam 2 dans les états anxiodépressifs [Randomised trial of L.72 (homeopathic speciality) with Diazepam 2 in cases of nervous depression.] Laboratoires Lehning, Metz; Unpublished study, 1985.
• 27 McCutcheon L. Treatment of anxiety with a homeopathic remedy. J Appl Nutr 1996; 48: 2-6.
• 28 Stanton H.E. Test anxiety—a five drop solution. Educ News 1981; 17: 12-15.
• 29 Thompson E.A., Montgomery A., Douglas D., Reilly D. A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors. J Altern Complement Med 2005; 11: 13-20.
• 30 Clover A., Last P., Fisher P., Wright S., Boyle H. Complementary cancer therapy: a pilot study of patients, therapies and quality of life. Complement Ther Med 1995; 3: 129-133.
• 31 Davidson J.R.T., Morrison R.M., Shore J., Davison R.T., Bedayn G. Homeopathic treatment of depression and anxiety. Altern Ther Health Med 1997; 3: 46-49.
• 32 Thompson E.A., Reilly D. The homeopathic approach to symptom control in the cancer patient: a prospective observational study. Palliat Med 2002; 16: 227-233.
• 33 Thompson E.A., Reilly D. The homeopathic approach to the treatment of symptoms of oestrogen withdrawal in breast cancer patients. A prospective observational study. Homeopathy 2003; 92: 131-134.
• 34 Vainchtock A., Dansette G.Y., Nicoloyannis N. et al. Medicoeconomic evaluation of management of anxiety disorders in outpatient care. Health and System Science 2000; 4: 103-155.
• 35 Benzecri J.P., Maiti G.D., Belon P., Questel R. Comparaison entre quatre méthodes de sevrage après une thérapeutique anxiolytique. [Comparison of four methods of withdrawal from anxiolytic therapy.]. Les Cahiers de l’Analyse des Données 1991; 16: 389-402.
• 36 Cialdella P., Boissel J.P., Belon P. Specialites homeopathiques en substitution de benzodiazepines: etude en double-insu vs. placebo [Homeopathic specialties as substitutes for benzodiazepines: double-blind vs. placebo study.]. Therapie 2001; 56: 397-402.
• 37 Gottwald R., Weiser M. Antihomotoxische Behandlung von Unruhezustanden mit und ohne Fieber bei Kindern: Ergebnisse einer Anwendungsbeobachtung. Biol Medizin 1999; 28: 308-312.
• 38 Oberbaum M., Schreiber R., Rosenthal C., Itzchaki M. Homeopathic treatment in emergency medicine: a case series. Homeopathy 2003; 92: 44-47.
• 39 Julian O.A. A comparative psychosomatic and pharmacological study, in man and animal, within homeopathic medicine. Annales de Therapeutique Psychiatrique 1967; 3: 305-309.
• 40 Zenner S., Weiser M. Homeopathic treatment of gynecological disorders: results of a prospective study. Biomed Ther 1999; 17: 31-35.
• 41 Hariveau E., Rufo M., Albertini C. Lithium Microsol dans le stress de l’ecolier. [Lithium microsol in school stress]. Homeopathie Francaise 1991; 79: 56-58.
• 42 Clover A. Patient benefit survey: Tunbridge Wells Homoeopathic Hospital. Br Homeopath J 2000; 89: 68-72.
• 43 Richardson W.R. Patient benefit survey: Liverpool Regional Department of Homoeopathic Medicine. Br Homeopath J 2001; 90: 158-162.
• 44 Dantas F., Rampes H. Do homeopathic medicines provoke adverse effects? A systematic review. Br Homeopath J 2000; 89: S35-S38 [Full text available at http://www.rlhh.org.uk/conference/ (Proceedings 2)].
• 45 Fisher P., Dantas F., Rampes H. The safety of homeopathic products. J R Soc Med 2002; 95: 474-475.
• 46 Sharples F., Van Haselen R., Fisher P. NHS patients’ perspective on complementary medicine. Complement Ther Med 2003; 11: 243-248.
• 47 McIntosh A, Cohen A, Turnbull N, et al. Clinical Guidelines and Evidence Review for Panic Disorder and Generalised Anxiety Disorder. Sheffield: University of Sheffield/London, National Collaborating Centre for Primary Care, 2004.
• 48 Wilson S., Delaney C., Roalfe A. et al. Randomised trials in primary care: case study. BMJ 2000; 321: 24-27.
• 49 Bell-Syer S., Moffett J. Recruiting patients to randomised trials in primary care: principles and case study. Fam Pract 2000; 17: 187-191.
• 50 Hunt C., Shepherd L., Andrews G. Do doctors know best? Comments on a failed trial. Med J Aust 2001; 174: 144-146.
• 51 Katz T., Fisher P., Katz A., Davidson J., Feder G. The feasibility of a randomised, placebo controlled clinical trial of homeopathic treatment of depression in general practice. Homeopathy 2005; 94: 145-152.
• 52 Jadad A.R., Moore R.A., Carroll D. et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17: 1-12.